| Objective: To evaluate the efficacy and safety of modular motion mode rehabilitation robot for spinal cord injury patients.
Methods: One handred patients with spinal cord injury hospitalized in the Beijing Bo'ai Hospital from December 2019 to October 2023 were recruited and divided into control group(n=50) and experimental group(n=50). All patients received routine treatment. Based on this, the control group received conventional physical therapy administered by professional rehabilitation therapists for 60min every day, and the experimental group received rehabilitation robot training for 60min every day for 6 weeks. The International Standard for Neurological Classification of Spinal Cord Injury(ISNCSCI), Modified Barthel Index(MBI), Spinal Cord Injury Independence Measure III(SCIM-III), vital signs(blood pressure, pulse, and respiration), and adverse event records were used to evaluate efficacy and safety before and after treatment.
Results: After treatment, the motor score, MBI and SCIM-III scores of both groups were significantly improved(P < 0.001).The scores of light touch and pin prick in experimental group were significantly improved(P < 0.05), while no significant improvements were seen in control group(P > 0.05). After treatment, the SCIM-III score of the experimental group was better than that of the control group(P < 0.05), but there was no statistical difference in other indexes(P > 0.05).
Conclusion: Both the modular motion mode rehabilitation robot and conventional physical therapy can improve motor function, enhance the activities of daily living and self-reliance of patients with spinal cord injury. Notably, the modular motion mode rehabilitation robot is more helpful to improve the self-reliance and the sensory function of patients. In addition, the robot innovatively enables limb linkage and postural transitions on a single device, providing safe and effective assistance for rehabilitation training and positional changes in patients with cervical or high-thoracic spinal cord injury. |